We are live on ! Find out more
ALXN

Alexion Pharmaceuticals
ALXN

Delisted

ALXN was delisted on the 20th of July, 2021.

Back to rankings

7 hedge funds and large institutions have $845K invested in Alexion Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 693 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

99% less funds holding

Funds holding: 707 → 7 (-700)

100% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 693

100% less funds holding in top 10

Funds holding in top 10: 77 → 0 (-77)

100% less capital invested

Capital invested by funds: $38.8B → $845K (-$38.8B)

Holders
7
Holders Change
-700
Holders Change %
-99.01%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
-77
Holding in Top 10 Change %
-100%
% of All Funds
–
New
1
Increased
2
Reduced
3
Closed
693
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
NICM
Neo Ivy Capital Management
New York
+$475K
2
TAIM
TD Ameritrade Investment Management
Nebraska
+$131K
3
RG
Retirement Group
California
+$9.37K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$3.74B
2
BlackRock
BlackRock
New York
-$3.21B
3
State Street
State Street
Massachusetts
-$1.84B
4
FCM
Farallon Capital Management
California
-$1.42B
5
HI
HBK Investments
Texas
-$1.21B
Name Holding Trade Value Shares
Change 		Change in
Stake
FTCM
126
First Trust Capital Management
Illinois
– -$43.6M -237,142 Closed
KBC Group
127
KBC Group
Belgium
– -$42.6M -232,052 Closed
Impax Asset Management Group
128
Impax Asset Management Group
United Kingdom
– -$42.4M -230,870 Closed
GC
129
Guggenheim Capital
Illinois
– -$41.8M -227,415 Closed
Voloridge Investment Management
130
Voloridge Investment Management
Florida
– -$40.5M -220,520 Closed
Russell Investments Group
131
Russell Investments Group
United Kingdom
– -$39.7M -216,189 Closed
MAM
132
Miria Asset Management
Malta
– -$38.5M -209,500 Closed
TEE
133
Tibra Equities Europe
United Kingdom
– -$37.6M -204,456 Closed
SSA
134
Schonfeld Strategic Advisors
New York
– -$35.6M -193,900 Closed
CU
135
CQS (US)
New York
– -$35.4M -192,722 Closed
GCIA
136
Gabelli & Co Investment Advisers
New York
– -$34.8M -189,497 Closed
Prudential Financial
137
Prudential Financial
New Jersey
– -$34.8M -189,305 Closed
GLAM
138
Gardner Lewis Asset Management
Pennsylvania
– -$34.3M -186,910 Closed
Skandinaviska Enskilda Banken (SEB)
139
Skandinaviska Enskilda Banken (SEB)
Sweden
– -$33.6M -182,821 Closed
AIMCA
140
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
– -$33.6M -182,793 Closed
AGM
141
Alpine Global Management
New York
– -$33.3M -181,403 Closed
AC
142
Athos Capital
Hong Kong
– -$33.2M -180,900 Closed
BNP Paribas Asset Management
143
BNP Paribas Asset Management
France
– -$33.2M -180,816 Closed
VanEck Associates
144
VanEck Associates
New York
– -$33M -179,488 Closed
Janus Henderson Group
145
Janus Henderson Group
United Kingdom
– -$32.6M -177,532 Closed
HHGC
146
Hunting Hill Global Capital
New York
– -$32M -174,236 Closed
State of Tennessee, Department of Treasury
147
State of Tennessee, Department of Treasury
Tennessee
– -$31.7M -172,482 Closed
Calamos Advisors
148
Calamos Advisors
Illinois
– -$31.2M -169,936 Closed
PF
149
Phoenix Financial
Israel
– -$29.9M -162,858 Closed
MCM
150
Moore Capital Management
New York
– -$28.9M -157,292 Closed
4 5
6
7 8

ALXN Hedge Fund Activity: Q3 2021 in Review

7 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Alexion Pharmaceuticals (ALXN) for Q3 2021, worth a combined $845K — down 100% from $38.8B a quarter earlier.

Sellers outnumbered buyers: 693 funds closed out of ALXN and 1 opened new positions — a net loss of 692 holders — while 3 trimmed existing stakes and 2 added.

The largest buyer was Neo Ivy Capital Management, opening a new position worth an estimated $475K. The largest seller was Vanguard Group, exiting entirely with an estimated $3.74B sold.

  • 7 institutional investors held Alexion Pharmaceuticals (ALXN) as of Q3 2021, down from 707 in Q2 2021.
  • Funds reported $845K of Alexion Pharmaceuticals stock for Q3 2021, down 100% quarter-over-quarter.
  • 1 fund opened new Alexion Pharmaceuticals positions in Q3 2021 and 693 closed out, a net change of -692 holders.
  • The largest Alexion Pharmaceuticals buyer in Q3 2021 was Neo Ivy Capital Management, an estimated $475K added.
  • The largest Alexion Pharmaceuticals seller in Q3 2021 was Vanguard Group, an estimated $3.74B sold.

Based on aggregated 13F filings for Q3 2021.